Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.
Cancers (Basel)
; 13(22)2021 Nov 11.
Article
in En
| MEDLINE
| ID: mdl-34830797
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Cancers (Basel)
Year:
2021
Type:
Article
Affiliation country:
Australia